Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

NCT04165564 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT04165564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04165564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
Lead sponsor
Boston University
Phase
Observational
Overall status
Active, not recruiting
Start date
August 24, 2020
Completion date
December 31, 2026
Enrollment
85 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease